Seminari VHIR - Dr. James A. Whitlock "Pediatric Precision Oncology: Promise and Pitfalls"

 
  Sala d'Actes, Hospital de la Dona i Infantil (HUVH) —
21/10/2019
21/10/2019 -- From 09:00h to 10:30h
Organize :
 Vall d'Hebron Institut de Recerca (VHIR)
Modality: Presencial
Share it:

Dr. James A. Whitlock, Division Head, Haematology/Oncology - Women's Auxiliary Millennium Chair in Haematology/Oncology -The Hospital for Sick Children - Prof of Paediatrics, University of Toronto, Canada.

"Pediatric Precision Oncology: Promise and Pitfalls"

I will discuss the promising results of a recently published first-in-children trial of the BRAF inhibitor dabrafenib for which I am a co-author, and then discuss some of the challenges facing pediatric oncologists in implementing molecularly targeted therapies, using the Canadian pediatric precision cancer program PROFYLE as an example.

Host: Paediatric Oncology and Haematology Dr. Lucas Moreno lucas. moreno@vhebron.net

 

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.